BRIEF published on 10/16/2025 at 06:50, 2 months 6 days ago ABB Reports Strong Q3 2025 Performance Revenue Growth Operational Performance Market Outlook Robotics Divestment ABB Financial Results
BRIEF published on 10/16/2025 at 06:50, 2 months 6 days ago ABB annonce de solides performances au troisième trimestre 2025 Croissance Des Revenus Perspectives Du Marché Performance Opérationnelle Désinvestissement Dans La Robotique Résultats Financiers D'ABB
BRIEF published on 10/16/2025 at 06:50, 2 months 6 days ago ABB Ltd Reports Strong Growth in Q3 2025 Revenue Growth ABB Ltd Q3 2025 Results Order Increase Robotics Divestment
BRIEF published on 10/16/2025 at 06:50, 2 months 6 days ago ABB Ltd annonce une forte croissance au troisième trimestre 2025 ABB Ltd Croissance Des Revenus Augmentation De La Commande Résultats Du Troisième Trimestre 2025 Désinvestissement Dans La Robotique
BRIEF published on 10/16/2025 at 06:45, 2 months 6 days ago Christian Nilsson Appointed CFO of ABB, Succeeding Timo Ihamuotila Automation Electrification Leadership Transition Christian Nilsson ABB Executive Committee
BRIEF published on 10/16/2025 at 06:45, 2 months 6 days ago Christian Nilsson nommé directeur financier d'ABB, succédant à Timo Ihamuotila Automation Electrification Transition De Leadership Christian Nilsson Comité Exécutif D'ABB
BRIEF published on 10/16/2025 at 06:35, 2 months 6 days ago VAT Group AG Reports 23% Sales Growth Amid Uncertainty Sales Growth Q3 Results VAT Group AG Market Outlook Semiconductors
BRIEF published on 10/16/2025 at 06:35, 2 months 6 days ago VAT Group AG annonce une croissance de ses ventes de 23 % dans un contexte d'incertitude Croissance Des Ventes Semi-conducteurs Perspectives Du Marché Résultats Du Troisième Trimestre Groupe TVA AG
BRIEF published on 10/16/2025 at 06:35, 2 months 6 days ago Actor Pharmaceuticals and Megalabs Partner for FYB203 Commercialization Formycon AG Eylea® Biosimilar Actor Pharmaceuticals Megalabs FYB203 Commercialization
BRIEF published on 10/16/2025 at 06:35, 2 months 6 days ago Actor Pharmaceuticals et Megalabs s'associent pour la commercialisation du FYB203 Formycon AG Biosimilaire Eylea® Megalabs Acteur Pharmaceutique Commercialisation Du FYB203
Published on 12/22/2025 at 14:00, 21 minutes ago Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 21 minutes ago PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants
Published on 12/22/2025 at 14:00, 21 minutes ago Tectonic Metals Drills 4.05 G/T AU Over 30.48 Meters, Including 8.84 G/T AU Over 13.72 Metres at Flat Gold Project, Alaska
Published on 12/22/2025 at 14:00, 21 minutes ago Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling
Published on 12/22/2025 at 13:35, 46 minutes ago DeFi Technologies Provides Clarifying Update on Share Ownership and Depository Imbalances and Outlines Next Steps and Announces Resignation of Director
Published on 12/22/2025 at 12:56, 1 hour 25 minutes ago Edison issues report on Edinburgh Worldwide Investment Trust (EWI)
Published on 12/22/2025 at 12:30, 1 hour 50 minutes ago EQS-Adhoc: ad pepper media International N.V. sells 60% stake in ad agents GmbH and realigns group's business model towards Webgains and solute
Published on 12/22/2025 at 09:18, 5 hours 3 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/22/2025 at 09:18, 5 hours 3 minutes ago GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025
Published on 12/19/2025 at 21:57, 2 days 16 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 3 days 5 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 3 days 5 hours ago Réduction du capital par voie d’annulation d’actions propres
